Skip to content

Examine the Psychosocial Impacts of COVID-19 Pandemic.

An International Study Examining the Psychosocial Impacts of COVID-19 Pandemic.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05052333
Enrollment
2574
Registered
2021-09-22
Start date
2021-12-01
Completion date
2023-10-31
Last updated
2023-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Pandemic, Psychosocial Impacts

Keywords

Psychological distress, Wellbeing, Mental health, Reliability and validity, Low and middle income countries, Cross-cultural comparisons

Brief summary

This is an observational study examining the psychosocial impacts of the COVID-19 pandemic in seven low-and-middle income countries (Indonesia, Iran, Iraq, Malaysia, Pakistan, Somaliland, and Turkiye). The data was obtained on standardised measures of wellbeing (WHO Well-Being Index), psychological distress (Kessler 10), post-traumatic stress (PTSD Checklist for DSM-5), post-traumatic growth (Posttraumatic Growth Inventory), and a novel pandemic-related stress (COVID Psychosocial Impacts Scale). Data was collected employing either a unilingual (in native language) or bilingual online survey (with English as a second language) from participants (N=2574) aged 18 and above using a non-probability convenient sampling. The findings enabled us to examine the psychosocial impacts of COVID-19, validate the translations of the CPIS and standardized measures; and determine the trajectory of study variables with pandemic exposure.

Interventions

None listed

Sponsors

International Islamic University, Islamabad
CollaboratorOTHER
Universitas Ahmad Dahlan
CollaboratorOTHER
Gadjah Mada University
CollaboratorOTHER
Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq
CollaboratorOTHER
Al-Mustansiriyah University
CollaboratorOTHER
Hasan Kalyoncu University
CollaboratorOTHER
University of Washington
CollaboratorOTHER
University of Malaya
CollaboratorOTHER
University of Social Welfare and Rehabilitation Science
CollaboratorOTHER
University of Otago
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Aged 18 and above * Currently residing in the country of interest. * Additional inclusion criterion applies to bilingual studies; which is having English as a second language.

Exclusion criteria

* Aged below 18 years. * Not residing in the country of interest. * Additional exclusion criterion applies to bilingual studies; which is not having English as a second language.

Design outcomes

Primary

MeasureTime frameDescription
Examining the psychosocial impacts of the COVID-19 pandemic.Data was collected in a short-time window on each site. The time of data collection varies across site and was collected from Dec 2021 to Sep 2023.To explore the psychosocial impacts of the COVID-19 pandemic on self-report measures of wellbeing (WHO-5), psychological distress (K10), post-traumatic stress (PCL-5), post-traumatic growth (PTGI), and pandemic-related stress (CPIS) in seven LMICs. The data will be collected employing a unilingual (Indonesia, Somaliland, Turkey) or bilingual (Iran, Iraq, Malaysia, Pakistan) survey. With-in-subjects and between-subjects designs together with exploratory regression analyses will be employed to characterize this outcome.

Other

MeasureTime frameDescription
Analyzing the psychometric properties of the translations of the newly developed CPIS and other standardized measures.The time of data collection varies across site and was collected from Dec 2021 to Sep 2023.The findings will give psychometric information on the translations and suitability of use of the newly developed CPIS and other standardized questionnaires (K10, WHO-5, PCL-5, PTGI) in seven LMICs. The metric used to characterize this outcome involves reliability (internal consistency) and validity (construct) analyses.

Countries

Indonesia, Iran, Iraq, Malaysia, Pakistan, Turkey (Türkiye), United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026